Video
28 Sep 2023

Our People, Our Brand

Watch Video

This video highlights our recognized and awarded CDMO leadership in the categories of Service, Quality, Capabilities, Expertise, Reliability and Compatibility.Watch the video for a glance at our company's culture and working principles and how we integrate all our skills together to meet the needs of our customers.

Read more Show less
Content provided by our supplier

FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS

  • GR
  • 2020
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
Manufacturer/Innovator
View company profile

Other Content from FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS (1)

  • FAMAR and Medicom Healthcare announce the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST

    News FAMAR and Medicom Healthcare announce the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST

    Medicom Healthcare Limited (Medicom) and Famar Health Care Services Madrid (Famar) are pleased to announce the signing of an Asset Purchase Agreement (APA) for the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST 0.3 mg/mL, 3ml, preservative free eye drop solution, developed by Famar R&D. Medicom and Famar have also entered into a long term Manufacturing and Supply Agreement (MSA) with Famar being the exclusive manufacturer of this product.
    10 Feb 2021